Literature DB >> 1520078

A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features.

R DeLong1, T Siddique.   

Abstract

We describe a large New England kindred bearing an autosomal dominant syndrome of neurogenic amyotrophy with variable expression. Features include congenital absence of muscles, progressive scapuloperoneal atrophy, laryngeal palsy, and progressive distal weakness and atrophy. The pattern of expression and progression varies in different branches of the family. Males are more severely affected than females. Disease expression is more severe and progressive in succeeding (third and fourth) generations. This striking increase in severity and progressivity in succeeding generations may have genetic implications. The syndrome most resembles the Stark-Kaeser chronic scapuloperoneal amyotrophy, but is considered a distinct entity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520078     DOI: 10.1001/archneur.1992.00530330027010

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

1.  TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies.

Authors:  C J Klein; Y Shi; F Fecto; M Donaghy; G Nicholson; M E McEntagart; A H Crosby; Y Wu; H Lou; K M McEvoy; T Siddique; H-X Deng; P J Dyck
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

2.  Axonal neuropathy-associated TRPV4 regulates neurotrophic factor-derived axonal growth.

Authors:  Yongwoo Jang; Jooyoung Jung; Hyungsup Kim; Jungeun Oh; Ji Hyun Jeon; Saewoon Jung; Kyung-Tai Kim; Hawon Cho; Dong-Jin Yang; Sung Min Kim; In-Beom Kim; Mi-Ryoung Song; Uhtaek Oh
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

3.  CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene.

Authors:  D-H Chen; Y Sul; M Weiss; A Hillel; H Lipe; J Wolff; M Matsushita; W Raskind; T Bird
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

4.  Mutant TRPV4-mediated toxicity is linked to increased constitutive function in axonal neuropathies.

Authors:  Faisal Fecto; Yong Shi; Rafiq Huda; Marco Martina; Teepu Siddique; Han-Xiang Deng
Journal:  J Biol Chem       Date:  2011-03-21       Impact factor: 5.157

5.  Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.

Authors:  Magdalena Zimoń; Jonathan Baets; Michaela Auer-Grumbach; José Berciano; Antonio Garcia; Eduardo Lopez-Laso; Luciano Merlini; David Hilton-Jones; Meriel McEntagart; Andrew H Crosby; Nina Barisic; Eugen Boltshauser; Christopher E Shaw; Guida Landouré; Christy L Ludlow; Rachelle Gaudet; Henry Houlden; Mary M Reilly; Kenneth H Fischbeck; Charlotte J Sumner; Vincent Timmerman; Albena Jordanova; Peter De Jonghe
Journal:  Brain       Date:  2010-05-11       Impact factor: 13.501

Review 6.  Recent advances in the genetics of hereditary axonal sensory-motor neuropathies type 2.

Authors:  Senda Ajroud-Driss; Han-Xiang Deng; Teepu Siddique
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 7.  Clinical genetics of Charcot-Marie-Tooth disease.

Authors:  Yujiro Higuchi; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-03-18       Impact factor: 3.755

Review 8.  The puzzle of TRPV4 channelopathies.

Authors:  Bernd Nilius; Thomas Voets
Journal:  EMBO Rep       Date:  2013-01-11       Impact factor: 8.807

9.  Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.

Authors:  Han-Xiang Deng; Christopher J Klein; Jianhua Yan; Yong Shi; Yanhong Wu; Faisal Fecto; Hau-Jie Yau; Yi Yang; Hong Zhai; Nailah Siddique; E Tessa Hedley-Whyte; Robert Delong; Marco Martina; Peter J Dyck; Teepu Siddique
Journal:  Nat Genet       Date:  2009-12-27       Impact factor: 38.330

10.  Charcot-Marie-Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation.

Authors:  Georgios Koutsis; David Lynch; Andreea Manole; Andreea Manone; Georgia Karadima; Mary M Reilly; Henry Houlden; Marios Panas
Journal:  J Neurol       Date:  2015-06-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.